Headline
The latest stories from AHA Today.
Physician burnout and satisfaction with work-life integration improved in the United States between 2014 and 2017, but there is still room for improvement, according to a study reported today in Mayo Clinic Proceedings.
The Department of Veterans Affairs today proposed the criteria for determining when covered veterans may elect to receive necessary hospital, medical and extended care services from non-VA entities or providers under the Veterans Community Care Program. The AHA-supported MISSION Act of 2018…
The Department of Health and Human Services has updated its guidance to help communities prepare for and respond to chemical incidents requiring mass decontamination.
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic last week held a webinar on the work it will undertake over the next two years to share knowledge, align initiatives and advance multisector solutions to improve outcomes for those impacted by the opioid…
National health expenditures are projected to grow an average 5.5 percent annually during 2018-2027, outpacing average projected growth in gross domestic product by 0.8 percentage point.
The Centers for Medicare & Medicaid Services has extended the deadline for submitting third-quarter data to the Post-Acute Care Quality Reporting Program.
The Kaiser Permanente School of Medicine will waive all tuition for the full four years of school for its first five classes.
The AHA today unveiled a set of principles to help inform the ongoing federal policy debate regarding surprise billing.
“The last thing a patient should worry about in a health crisis is an unanticipated medical bill,” said AHA President and CEO Rick Pollack. “We must protect patients from…
National hospital organizations, including the AHA, today urged congressional leaders to delay the start of the Medicaid disproportionate share hospital cuts that are scheduled to begin in fiscal year 2020.
The AHA today urged the Centers for Medicare & Medicaid Services to consider alternative payment solutions to promote beneficiary access to chimeric antigen receptor T-cell (CAR T) therapy and other new technologies.